PROT# CQAX576A2205: A Double-Blinded, Randomized, Placebo-Controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis

Project: Research project

Project Details

StatusFinished
Effective start/end date11/2/09 → 7/31/11

Funding

  • Novartis Pharmaceuticals Corporation (PROT# CQAX576A2205)